Carregant...
Anti‐PCSK9 antibodies for hypercholesterolaemia: Overview of clinical data and implications for primary care
OBJECTIVES: To put data from our recent systematic review of phase 3 studies of anti‐proprotein convertase subtilisin/kexin type 9 (PCSK9) antibodies into the context of clinical practice. METHODS: Data from studies previously identified by a systematic review of phase 3 studies of alirocumab and ev...
Guardat en:
| Publicat a: | Int J Clin Pract |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5601297/ https://ncbi.nlm.nih.gov/pubmed/28750477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijcp.12979 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|